vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Navios Maritime Partners L.P. (NMM). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $327.6M, roughly 1.2× Navios Maritime Partners L.P.). Navios Maritime Partners L.P. runs the higher net margin — 21.4% vs 5.3%, a 16.1% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Navios Maritime Holdings Inc. is a multinational, vertically integrated seaborne shipping and logistics company focused on the transport and transshipment of drybulk commodities including iron ore, coal and grain.
GRDN vs NMM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | ||
|---|---|---|
| Revenue | $397.6M | $327.6M |
| Net Profit | $20.9M | $69.9M |
| Gross Margin | 21.5% | 90.5% |
| Operating Margin | 7.7% | — |
| Net Margin | 5.3% | 21.4% |
| Revenue YoY | — | -4.3% |
| Net Profit YoY | — | -31.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | — | ||
| Q3 25 | $377.4M | — | ||
| Q2 25 | $344.3M | $327.6M | ||
| Q1 25 | $329.3M | — | ||
| Q3 24 | $314.4M | — | ||
| Q2 24 | — | $342.2M | ||
| Q2 23 | — | $346.9M | ||
| Q2 22 | — | $280.7M |
| Q4 25 | $20.9M | — | ||
| Q3 25 | $9.8M | — | ||
| Q2 25 | $9.0M | $69.9M | ||
| Q1 25 | $9.4M | — | ||
| Q3 24 | $-122.0M | — | ||
| Q2 24 | — | $101.5M | ||
| Q2 23 | — | $112.3M | ||
| Q2 22 | — | $118.2M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | 90.5% | ||
| Q1 25 | 19.5% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | 88.3% | ||
| Q2 23 | — | 87.9% | ||
| Q2 22 | — | 92.3% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.9% | — | ||
| Q3 24 | -33.3% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.6% | 21.4% | ||
| Q1 25 | 2.9% | — | ||
| Q3 24 | -38.8% | — | ||
| Q2 24 | — | 29.7% | ||
| Q2 23 | — | 32.4% | ||
| Q2 22 | — | 42.1% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $377.0M |
| Total DebtLower is stronger | $0 | $2.0B |
| Stockholders' EquityBook value | $217.9M | — |
| Total Assets | $412.7M | $5.9B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | — | ||
| Q3 25 | $36.5M | — | ||
| Q2 25 | $18.8M | $377.0M | ||
| Q1 25 | $14.0M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | — | $272.0M | ||
| Q2 23 | — | $261.4M | ||
| Q2 22 | — | $163.4M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | $1.4B | ||
| Q2 23 | — | $1.6B | ||
| Q2 22 | — | $1.1B |
| Q4 25 | $217.9M | — | ||
| Q3 25 | $195.5M | — | ||
| Q2 25 | $179.7M | — | ||
| Q1 25 | $163.2M | — | ||
| Q3 24 | $133.9M | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | $2.6B | ||
| Q2 22 | — | $2.0B |
| Q4 25 | $412.7M | — | ||
| Q3 25 | $390.0M | — | ||
| Q2 25 | $356.3M | $5.9B | ||
| Q1 25 | $334.0M | — | ||
| Q3 24 | $348.0M | — | ||
| Q2 24 | — | $5.3B | ||
| Q2 23 | — | $5.0B | ||
| Q2 22 | — | $3.7B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | 0.64× | ||
| Q2 22 | — | 0.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | — | ||
| Q3 25 | $28.2M | — | ||
| Q2 25 | $19.9M | — | ||
| Q1 25 | $17.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $24.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.